Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

25,720 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 7,363
Recruiting: 3,965
Ph III recruiting: 535
Growth YoY: +10.3%
Industry share: 25%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.1%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (3,404)

clinicaltrialsPublishedShowing 501–521 of 521 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00999843	Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver Cancer	unknown	Phase 1 / Phase 2	30	Fudan UniversityOTHER	1	Oct 22, 2009	clinicaltrials
NCT00960167	A Dose Escalation Trial of Radiation Therapy (RT) for Hepatocellular Carcinoma (HCC)	unknown	Phase 1	20	National Taiwan University HospitalOTHER	1	Oct 15, 2009	clinicaltrials